Redeye adjusts its view of Imint following a review of the case after the Q1’20 report. The company has so far handled the Corona crisis well, and we maintain our 2020 estimates. However, after a closer examination of the demanding dynamics of the smartphone market, we adjust our valuation range slightly downwards.
Read more and download the research update: https://bit.ly/2YYnLyq
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking. https://www.redeye.se/about/
